Advertorial, B. 2017. Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION. SA Heart Journal. 13, 1 (Mar. 2017), 42–43. DOI:https://doi.org/10.24170/13-1-1694.